Apr 30, 2019
Tim Brennan is director of the Addiction Institute at Mount Sinai West and Mount Sinai St. Luke's hospitals. He discusses the why and how of transitioning a patient from methadone to buprenorphine, and dispels some common misperceptions that patients and providers have about these treatments. You can learn more about the treatment of substance use disorders, including buprenorphine prescribing, at www.psychiatry.org. Information about the Providers’ Clinical Support System can be found at www.pcssNOW.org. Funding for this initiative was made possible (in part) by grant no. 5U79TI026556-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. We want to know more about Medical Mind listeners! Take a minute to complete a brief listener survey at http://apapsy.ch/mmsurvey. Music: "Sidecar" by Podington Bear